Publicly Traded Molecular Diagnostic CompaniesU.S. Exchanges
List of Publicly Traded Molecular Diagnostic Companies Listed on Major U.S. Exchanges
The companies on this list are molecular diagnostic and genetic testing companies that develop, manufacture, market and provide diagnostic tests, diagnostic systems and related products and services. These products and services are designed to help in the detection of diseases and provide information for optimal patient treatment.
Additional diagnostics companies can be found in our Diagnostics section.
Additional publicly traded healthcare companies and healthcare categories can be accessed through the link below:
A comparison widget that shows trend, earnings per share (EPS), P/E ratio and beta for each of the companies on this list can be accessed through the link below.
Select the company’s link to access charts, news links and company website and social media information.
Molecular Diagnostics: Mid-Cap Stocks
EXACT Sciences Corporation (EXAS) (Molecular oncology)
Molecular Diagnostics: Small-Cap Stocks
GenMark Diagnostics, Inc. (GNMK) (Cystic fibrosis, respiratory viral)
Genomic Health, Inc. (GHDX) (Molecular oncology)
Invitae Corporation (NVTA) (Genetic diagnostics for hereditary disorders)
Myriad Genetics, Inc. (MYGN) (Hereditary cancer, nephrology, autoimmune diseases, diabetes, neuropsychiatry)
Natera Inc. (NTRA) (IPO in July 2015: Genetic testing and diagnostics company)
Molecular Diagnostics: Micro-Cap Stocks
Cancer Genetics, Inc. (CGIX) (DNA-based diagnostics)
HTG Molecular Diagnostics, Inc. (HTGM) (IPO in May 2015: molecular profiling)
Veracyte, Inc. (VCYT) (Molecular cytology)
Molecular Diagnostics: Nano-Cap Stocks
Biocept, Inc. (BIOC) (Molecular oncology)
Co-Diagnostics, Inc. (CODX) (IPO July 12, 2017; molecular diagnostics)
Genetic Technologies Ltd. (GENE) (Molecular diagnostics: cancer management tests)
OpGen, Inc. (OPGN) (IPO in May 2015: Diagnostics; molecular testing and bioinformatics)